Quick Takeaways
- Jasbir Seehra has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $8,972,814.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jasbir Seehra
- Location
- Waltham, MA
- Summary
- The estimated net worth of Jasbir Seehra is at least $8,972,814 dollars as of 06 Apr 2026. Jasbir Seehra is the CHIEF EXECUTIVE OFFICER, Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $8.97M.
- Signature
- /s/ Jasbir Seehra
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jasbir Seehra and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Keros Therapeutics, Inc. ($8,972,814).
- Past-year value change for that position: -$113,433.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Jasbir Seehra
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | $8,972,814 | -$113,433 | -1.2% | 02 Apr 2026 |
| ELOX | Eloxx Pharmaceuticals, Inc. | Director | 15 Jun 2022 |
Insider Transactions Reported by Jasbir Seehra:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.